Key committees have not marked up and sent to the floor three separate bills that would:
- Require price disclosure by hospitals, physicians, drugmakers and pharmacies.
- Direct HHS to review rate increases in states where insurance commissioners don’t have that authority.
- Remove health insurers’ exemption from the federal antitrust law.
House Speaker Nancy Pelosi (D-Calif.) said she wanted to focus on “jobs, jobs, jobs, jobs.”
Energy and Commerce Committee Chairman Henry Waxman (D-Calif.) acknowledged House members “would be wary of major health legislation after we’ve spent so much time [on the reform law]. We do have other priorities.”
Sen. Ben Nelson (D-Neb.) suggested the antitrust measure wasn’t necessary because “every state has an antitrust law. Why do you need a federal antitrust law?”
Read the Hill‘s report on health reform.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
